Shelly Adler was Appointed as Director, Benefits at Sage Therapeutics

Date of management change: October 17, 2019 

What Happened?

Cambridge, MA-based Sage Therapeutics Appointed Shelly Adler as Director, Benefits


About the Company

Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage`s lead product candidate, ZULRESSO(TM) (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression.


About the Person

Shelly Adler is Director, Benefits at Sage Therapeutics. Previously, Shelly held various senior HR leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Krasowski Valerie, Bott Alison, O'Brien Joseph, Brown Rodney, Livingston Jim, Alberts Katherine, Braden Brianna, Camarillo Laura, Shaner Susan, Evangelista Salvador, Holmes Lindsay

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.